Szczepan Cierniak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Szczepan Cierniak has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Tomasz Markiewicz
Warsaw University of Technology
5 shared publications Malgorzata Lorent
2 shared publications- Sławomir Lewicki
Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy in Warsaw, Pl. Żelaznej Bramy 10, 00-136 Warsaw, Poland
2 shared publications - Tomasz Les
Faculty of Electrical Engineering, Warsaw University of Technology, ul. Koszykowa 75, 00-662 Warszawa, Poland
2 shared publications - Zaneta Swiderska-Chadaj
Warsaw University of Technology
2 shared publications - Łukasz Szymański
Department of Molecular Biology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Magdalenka, Poland
2 shared publications
Latest Publications
- Open Access
- 31 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 6054
Breast Cancer Plasticity after Chemotherapy Highlights the Need for Re-Evaluation of Subtyping in Residual Cancer and Metastatic Tissues
This research paper presents a novel approach to identifying biomarkers that can be used to prognosticate patients with triple-negative breast cancer (TNBC) eligible for neoadjuvant therapy. The study utilized survival and RNA sequencing data from a cohort of TNBC patients and identified 276 genes whose expression was related to survival in such patients. The gene expression data were then used to classify patients into two major groups based on the presence or absence of Wingless/Integrated-pathway (Wnt-pathway) and mesenchymal (Mes) markers (Wnt/Mes). Patients with a low expression of Wnt/Mes-related genes had a favorable outcome, with no deaths observed during follow-up, while patients with a high expression of Wnt/Mes genes had a higher mortality rate of 50% within 19 months. The identified gene list could be validated and potentially used to shape treatment options for TNBC patients eligible for neoadjuvant therapy providing valuable insights into the development of more effective treatments for TNBC. Our data also showed significant variation in gene expression profiles before and after chemotherapy, with most tumors switching to a more mesenchymal/stem cell-like profile. To verify this observation, we performed an in silico analysis to classify breast cancer tumors in Prediction Analysis of Microarray 50 (PAM50) molecular classes before treatment and after treatment using gene expression data. Our findings demonstrate that following drug intervention and metastasis, certain tumors undergo a transition to alternative subtypes, resulting in diminished therapeutic efficacy. This underscores the necessity for reevaluation of patients who have experienced relapse or metastasis post-chemotherapy, with a focus on molecular subtyping. Tailoring treatment strategies based on these refined subtypes is imperative to optimize therapeutic outcomes for affected individuals.
- 31 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 6054
Open AccessBreast Cancer Plasticity after Chemotherapy Highlights the Need for Re-Evaluation of Subtyping in Residual Cancer and Metastatic Tissues
This research paper presents a novel approach to identifying biomarkers that can be used to prognosticate patients with triple-negative breast cancer (TNBC) eligible for neoadjuvant therapy. The study utilized survival and RNA sequencing data from a cohort of TNBC patients and identified 276 genes whose expression was related to survival in such patients. The gene expression data were then used to classify patients into two major groups based on the presence or absence of Wingless/Integrated-pathway (Wnt-pathway) and mesenchymal (Mes) markers (Wnt/Mes). Patients with a low expression of Wnt/Mes-related genes had a favorable outcome, with no deaths observed during follow-up, while patients with a high expression of Wnt/Mes genes had a higher mortality rate of 50% within 19 months. The identified gene list could be validated and potentially used to shape treatment options for TNBC patients eligible for neoadjuvant therapy providing valuable insights into the development of more effective treatments for TNBC. Our data also showed significant variation in gene expression profiles before and after chemotherapy, with most tumors switching to a more mesenchymal/stem cell-like profile. To verify this observation, we performed an in silico analysis to classify breast cancer tumors in Prediction Analysis of Microarray 50 (PAM50) molecular classes before treatment and after treatment using gene expression data. Our findings demonstrate that following drug intervention and metastasis, certain tumors undergo a transition to alternative subtypes, resulting in diminished therapeutic efficacy. This underscores the necessity for reevaluation of patients who have experienced relapse or metastasis post-chemotherapy, with a focus on molecular subtyping. Tailoring treatment strategies based on these refined subtypes is imperative to optimize therapeutic outcomes for affected individuals.
- Open Access
- 6 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4522
Selected Immunohistochemical Assessment and Clinical Examinations in the Diagnosis of Palatine Tonsil Diseases
Introduction: The palatine tonsils are secondary lymphoid organs where immune processes occur, influencing the development of a targeted cellular and humoral response. The diseased tonsils are subject to immunological imbalances, including the activity of pro-inflammatory and anti-inflammatory factors. This leads to the development of palatine tonsil diseases, such as palatine tonsillitis and palatine tonsillar hypertrophy. Aim: The main aim of the study was to evaluate the similarities and differences in the clinical and pathomorphological pictures of patients qualified for surgical treatment due to hypertrophy or inflammation of the palatine tonsils. The aim was achieved by demonstrating the relationship between the patient’s medical history and physical examination and histopathological diagnosis of a given tonsillar disease, evaluating the usefulness of basic blood tests (leukocytosis, ASO, ESR, and CRP) in differential diagnosis, and assessing the immunohistochemical assessment of palatine tonsil tissue. Material and Methods: The tonsils were stained with the following antibodies: IL-1, IL-2, IL-6, IL-8 IL-10, and IL-37 and CD25, CD40, and CD69, taking into account the histological division of the studied lymphatic tissue (epithelial, subepithelial, follicular, follicular center, and interfollicular). Patients aged between 19 and 70 years with tonsillitis or clinical signs of tonsillar hypertrophy were qualified for tonsillectomy/UPPP. Seventy-two males (68.6%) and thirty-three females (31.4%) were enrolled in the study. Histopathological and immunohistochemical assessment was performed on 105 palatine tonsils. Results: The diagnostic value of blood tests, including determination of ASO, ESR, CRP, and leukocyte level, proved to be a significant predictor of tonsil disease. In the pathomorphological assessment, 75% of the subjects who had simultaneously elevated ESR (>4.73) and leukocytosis (>6.96) and reduced ASO (p < 0.05 between the study groups was only noted in the subepithelial region. It should be emphasized that for the data as a whole (calculated on the basis of the data for all regions together), no statistically significant differences were observed. Conclusion: In conclusion, the results obtained are indicative of the presence of a specific immunohistochemical profile for palatine tonsil diseases. Significant discrepancies have been found in the clinical and pathomorphological assessment of tonsils qualified for tonsillectomy. Therefore, these methods should be considered complementary. The patient’s medical history and physical examination, depending on the adopted clinical or histopathological classification, show a variation in the distribution of features that are the basis for allocation to a particular group.
- 6 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4522
Open AccessSelected Immunohistochemical Assessment and Clinical Examinations in the Diagnosis of Palatine Tonsil Diseases
Introduction: The palatine tonsils are secondary lymphoid organs where immune processes occur, influencing the development of a targeted cellular and humoral response. The diseased tonsils are subject to immunological imbalances, including the activity of pro-inflammatory and anti-inflammatory factors. This leads to the development of palatine tonsil diseases, such as palatine tonsillitis and palatine tonsillar hypertrophy. Aim: The main aim of the study was to evaluate the similarities and differences in the clinical and pathomorphological pictures of patients qualified for surgical treatment due to hypertrophy or inflammation of the palatine tonsils. The aim was achieved by demonstrating the relationship between the patient’s medical history and physical examination and histopathological diagnosis of a given tonsillar disease, evaluating the usefulness of basic blood tests (leukocytosis, ASO, ESR, and CRP) in differential diagnosis, and assessing the immunohistochemical assessment of palatine tonsil tissue. Material and Methods: The tonsils were stained with the following antibodies: IL-1, IL-2, IL-6, IL-8 IL-10, and IL-37 and CD25, CD40, and CD69, taking into account the histological division of the studied lymphatic tissue (epithelial, subepithelial, follicular, follicular center, and interfollicular). Patients aged between 19 and 70 years with tonsillitis or clinical signs of tonsillar hypertrophy were qualified for tonsillectomy/UPPP. Seventy-two males (68.6%) and thirty-three females (31.4%) were enrolled in the study. Histopathological and immunohistochemical assessment was performed on 105 palatine tonsils. Results: The diagnostic value of blood tests, including determination of ASO, ESR, CRP, and leukocyte level, proved to be a significant predictor of tonsil disease. In the pathomorphological assessment, 75% of the subjects who had simultaneously elevated ESR (>4.73) and leukocytosis (>6.96) and reduced ASO (p < 0.05 between the study groups was only noted in the subepithelial region. It should be emphasized that for the data as a whole (calculated on the basis of the data for all regions together), no statistically significant differences were observed. Conclusion: In conclusion, the results obtained are indicative of the presence of a specific immunohistochemical profile for palatine tonsil diseases. Significant discrepancies have been found in the clinical and pathomorphological assessment of tonsils qualified for tonsillectomy. Therefore, these methods should be considered complementary. The patient’s medical history and physical examination, depending on the adopted clinical or histopathological classification, show a variation in the distribution of features that are the basis for allocation to a particular group.
- Open Access
Clinical, Dermoscopic, and Histological Characteristics of Melanoma Patients According to the Age Groups: A Retrospective Observational Study
Background: Although the role of melanoma risk factors is well documented, their correlation with patients’ age is less frequently analyzed. Method: The analysis was performed among 189 melanoma patients in different age groups, including 60 years, to investigate the risk factors, topography, and coexistence of morphological features of 209 melanomas (dermoscopic and histopathological). Results: Among the youngest age group, no correlation with the presence of estimated risk factors was found. The most common dermoscopic pattern was spitzoid and multicomponent asymmetric. The group of middle-aged patients was the most diverse in terms of the occurrence of risk factors, solar lentiginosis, dermoscopic patterns, topography, histological subtypes, and invasiveness of melanomas. The oldest group characterized a strong correlation between solar lentiginosis, NMSC comorbidity, the prevalence of facial melanomas, the dermoscopic pattern of melanoma arising on chronic sun-damaged skin, and regression. Conclusion: The findings regarding the presence of age-specific features in melanoma patients, especially in the youngest and middle-aged groups, might be helpful for clinicians and to target secondary prevention efforts.
Open AccessClinical, Dermoscopic, and Histological Characteristics of Melanoma Patients According to the Age Groups: A Retrospective Observational Study
Background: Although the role of melanoma risk factors is well documented, their correlation with patients’ age is less frequently analyzed. Method: The analysis was performed among 189 melanoma patients in different age groups, including 60 years, to investigate the risk factors, topography, and coexistence of morphological features of 209 melanomas (dermoscopic and histopathological). Results: Among the youngest age group, no correlation with the presence of estimated risk factors was found. The most common dermoscopic pattern was spitzoid and multicomponent asymmetric. The group of middle-aged patients was the most diverse in terms of the occurrence of risk factors, solar lentiginosis, dermoscopic patterns, topography, histological subtypes, and invasiveness of melanomas. The oldest group characterized a strong correlation between solar lentiginosis, NMSC comorbidity, the prevalence of facial melanomas, the dermoscopic pattern of melanoma arising on chronic sun-damaged skin, and regression. Conclusion: The findings regarding the presence of age-specific features in melanoma patients, especially in the youngest and middle-aged groups, might be helpful for clinicians and to target secondary prevention efforts.
- 12 October 2022
- Published by Wojskowy Instytut Medyczny – Panstwowy Instytut Badawczy in Lekarz Wojskowy
- Vol. 100 (3) , 203-206
The pathomorphology report is the basis of oncological treatment
Współczesna patomorfologia jest kluczową dziedziną medycyny, bez której leczenie chorób nowotworowych byłoby praktycznie niemożliwe. Ma wpływ nie tylko na ratowanie, ale również na jakość życia pacjentów. Formalną podstawą rozpoczęcia jakiegokolwiek leczenia onkologicznego jest raport patomorfologiczny zawierający wiele informacji koniecznych do ustalenia leczenia, które będzie skuteczne i jednocześnie bezpieczne dla danego pacjenta. Aby to było możliwe, patomorfolog musi mieć dostęp do kompletnych danych medycznych pacjenta, jego przeszłości onkologicznej oraz typu zastosowanego wcześniej leczenia. Niestety dość często otrzymuje dalece niekompletne dane, co skutkuje zarówno wydłużeniem czasu, jak i zwiększonymi kosztami takich badań. Dlatego niezbędna jest właściwa komunikacja między patologami i klinicystami oraz wystandaryzowanie każdego elementu postępowania z materiałem tkankowym bądź cytologicznym pobieranym do badania patomorfologicznego.
- 12 October 2022
- Published by Wojskowy Instytut Medyczny – Panstwowy Instytut Badawczy in Lekarz Wojskowy
- Vol. 100 (3) , 203-206
The pathomorphology report is the basis of oncological treatment
Współczesna patomorfologia jest kluczową dziedziną medycyny, bez której leczenie chorób nowotworowych byłoby praktycznie niemożliwe. Ma wpływ nie tylko na ratowanie, ale również na jakość życia pacjentów. Formalną podstawą rozpoczęcia jakiegokolwiek leczenia onkologicznego jest raport patomorfologiczny zawierający wiele informacji koniecznych do ustalenia leczenia, które będzie skuteczne i jednocześnie bezpieczne dla danego pacjenta. Aby to było możliwe, patomorfolog musi mieć dostęp do kompletnych danych medycznych pacjenta, jego przeszłości onkologicznej oraz typu zastosowanego wcześniej leczenia. Niestety dość często otrzymuje dalece niekompletne dane, co skutkuje zarówno wydłużeniem czasu, jak i zwiększonymi kosztami takich badań. Dlatego niezbędna jest właściwa komunikacja między patologami i klinicystami oraz wystandaryzowanie każdego elementu postępowania z materiałem tkankowym bądź cytologicznym pobieranym do badania patomorfologicznego.
- 17 September 2022
- Published by Elsevier in Expert Systems with Applications
- Vol. 213
Improvement of renal image recognition through resolution enhancement
- 17 September 2022
- Published by Elsevier in Expert Systems with Applications
- Vol. 213
Improvement of renal image recognition through resolution enhancement
- Open Access
Evaluation of Polysaccharide–Peptide Conjugates Containing the RGD Motif for Potential Use in Muscle Tissue Regeneration
New scaffold materials composed of biodegradable components are of great interest in regenerative medicine. These materials should be: stable, nontoxic, and biodegrade slowly and steadily, allowing the stable release of biodegradable and biologically active substances. We analyzed peptide-polysaccharide conjugates derived from peptides containing RGD motif (H-RGDS-OH (1), H-GRGDS-NH2 (2), and cyclo(RGDfC) (3)) and polysaccharides as scaffolds to select the most appropriate biomaterials for application in regenerative medicine. Based on the results of MTT and Ki-67 assays, we can state that the conjugates containing calcium alginate and the ternary nonwoven material were the most supportive of muscle tissue regeneration. Scanning electron microscopy imaging and light microscopy studies with hematoxylin–eosin staining showed that C2C12 cells were able to interact with the tested peptide–polysaccharide conjugates. The release factor (Q) varied depending on both the peptide and the structure of the polysaccharide matrix. LDH, Alamarblue®, Ki-67, and cell cycle assays indicated that peptides 1 and 2 were characterized by the best biological properties. Conjugates containing chitosan and the ternary polysaccharide nonwoven with peptide 1 exhibited very high antibacterial activity against Staphylococcus aureus and Klebsiella pneumoniae. Overall, the results of the study suggested that polysaccharide conjugates with peptides 1 and 2 can be potentially used in regenerative medicine.
Open AccessEvaluation of Polysaccharide–Peptide Conjugates Containing the RGD Motif for Potential Use in Muscle Tissue Regeneration
New scaffold materials composed of biodegradable components are of great interest in regenerative medicine. These materials should be: stable, nontoxic, and biodegrade slowly and steadily, allowing the stable release of biodegradable and biologically active substances. We analyzed peptide-polysaccharide conjugates derived from peptides containing RGD motif (H-RGDS-OH (1), H-GRGDS-NH2 (2), and cyclo(RGDfC) (3)) and polysaccharides as scaffolds to select the most appropriate biomaterials for application in regenerative medicine. Based on the results of MTT and Ki-67 assays, we can state that the conjugates containing calcium alginate and the ternary nonwoven material were the most supportive of muscle tissue regeneration. Scanning electron microscopy imaging and light microscopy studies with hematoxylin–eosin staining showed that C2C12 cells were able to interact with the tested peptide–polysaccharide conjugates. The release factor (Q) varied depending on both the peptide and the structure of the polysaccharide matrix. LDH, Alamarblue®, Ki-67, and cell cycle assays indicated that peptides 1 and 2 were characterized by the best biological properties. Conjugates containing chitosan and the ternary polysaccharide nonwoven with peptide 1 exhibited very high antibacterial activity against Staphylococcus aureus and Klebsiella pneumoniae. Overall, the results of the study suggested that polysaccharide conjugates with peptides 1 and 2 can be potentially used in regenerative medicine.
- 18 July 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-7
HE-to-PAS histological stain conversion by GAN in renal pathology
This paper presents the evaluation of the accurate-ness of an automatic HE to PAS stain conversion. We collected the unique HE-PAS (stain and restain specimens) database of renal specimens, and we have developed and compared a set of GAN methods for the automatic staining conversion. The detailed evaluation includes 10 numerical metrics and a visual evaluation, which was performed to investigate and closely look at the accuracy of an automatic stain transformation. The main contribution and novelty of this paper is the multi-aspect evaluation of the accurateness of staining transformation using a unique HE-PAS stain-restain dataset. Achieved results show that an automatic HE to PAS staining conversion achieved Frechet Inception Distance (FID) metric below 7, whereas visual evaluation is up to 96%. Presented analysis and results give insights into possibilities to build automatic stain transformations tools to replace the need of performing manual staining.
- 18 July 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-7
HE-to-PAS histological stain conversion by GAN in renal pathology
This paper presents the evaluation of the accurate-ness of an automatic HE to PAS stain conversion. We collected the unique HE-PAS (stain and restain specimens) database of renal specimens, and we have developed and compared a set of GAN methods for the automatic staining conversion. The detailed evaluation includes 10 numerical metrics and a visual evaluation, which was performed to investigate and closely look at the accuracy of an automatic stain transformation. The main contribution and novelty of this paper is the multi-aspect evaluation of the accurateness of staining transformation using a unique HE-PAS stain-restain dataset. Achieved results show that an automatic HE to PAS staining conversion achieved Frechet Inception Distance (FID) metric below 7, whereas visual evaluation is up to 96%. Presented analysis and results give insights into possibilities to build automatic stain transformations tools to replace the need of performing manual staining.
- Top Cited PapersOpen Access
- 28 February 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (5) , 2437
Effect of Different Wavelengths of Laser Irradiation on the Skin Cells
The invention of systems enabling the emission of waves of a certain length and intensity has revolutionized many areas of life, including medicine. Currently, the use of devices emitting laser light is not only an indispensable but also a necessary element of many diagnostic procedures. It also contributed to the development of new techniques for the treatment of diseases that are difficult to heal. The use of lasers in industry and medicine may be associated with a higher incidence of excessive radiation exposure, which can lead to injury to the body. The most exposed to laser irradiation is the skin tissue. The low dose laser irradiation is currently used for the treatment of various skin diseases. Therefore appropriate knowledge of the effects of lasers irradiation on the dermal cells’ metabolism is necessary. Here we present current knowledge on the clinical and molecular effects of irradiation of different wavelengths of light (ultraviolet (UV), blue, green, red, and infrared (IR) on the dermal cells.
- 28 February 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (5) , 2437
Top Cited PapersOpen AccessEffect of Different Wavelengths of Laser Irradiation on the Skin Cells
The invention of systems enabling the emission of waves of a certain length and intensity has revolutionized many areas of life, including medicine. Currently, the use of devices emitting laser light is not only an indispensable but also a necessary element of many diagnostic procedures. It also contributed to the development of new techniques for the treatment of diseases that are difficult to heal. The use of lasers in industry and medicine may be associated with a higher incidence of excessive radiation exposure, which can lead to injury to the body. The most exposed to laser irradiation is the skin tissue. The low dose laser irradiation is currently used for the treatment of various skin diseases. Therefore appropriate knowledge of the effects of lasers irradiation on the dermal cells’ metabolism is necessary. Here we present current knowledge on the clinical and molecular effects of irradiation of different wavelengths of light (ultraviolet (UV), blue, green, red, and infrared (IR) on the dermal cells.
- Open Access
- 5 July 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-16
Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
Tumor-driven immune suppression is a major barrier to successful immunotherapy in ovarian carcinomas (OvCa). Among various mechanisms responsible for immune suppression, arginase-1 (ARG1)-carrying small extracellular vesicles (EVs) emerge as important contributors to tumor growth and tumor escape from the host immune system. Here, we report that small EVs found in the ascites and plasma of OvCa patients contain ARG1. EVs suppress proliferation of CD4+ and CD8+ T-cells in vitro and in vivo in OvCa mouse models. In mice, ARG1-containing EVs are transported to draining lymph nodes, taken up by dendritic cells and inhibit antigen-specific T-cell proliferation. Increased expression of ARG1 in mouse OvCa cells is associated with accelerated tumor progression that can be blocked by an arginase inhibitor. Altogether, our studies show that tumor cells use EVs as vehicles to carry over long distances and deliver to immune cells a metabolic checkpoint molecule – ARG1, mitigating anti-tumor immune responses.
- 5 July 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-16
Open AccessSmall extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
Tumor-driven immune suppression is a major barrier to successful immunotherapy in ovarian carcinomas (OvCa). Among various mechanisms responsible for immune suppression, arginase-1 (ARG1)-carrying small extracellular vesicles (EVs) emerge as important contributors to tumor growth and tumor escape from the host immune system. Here, we report that small EVs found in the ascites and plasma of OvCa patients contain ARG1. EVs suppress proliferation of CD4+ and CD8+ T-cells in vitro and in vivo in OvCa mouse models. In mice, ARG1-containing EVs are transported to draining lymph nodes, taken up by dendritic cells and inhibit antigen-specific T-cell proliferation. Increased expression of ARG1 in mouse OvCa cells is associated with accelerated tumor progression that can be blocked by an arginase inhibitor. Altogether, our studies show that tumor cells use EVs as vehicles to carry over long distances and deliver to immune cells a metabolic checkpoint molecule – ARG1, mitigating anti-tumor immune responses.
- 1 July 2019
- Published by Evereth Publishing in Forum Zakażeń
- Vol. 10 (3) , 151-157
Przestrzeganie procedur higieny rąk przez pracowników ośrodka diagnostyki medycznej wojskowego instytutu medycznego w Warszawie
- 1 July 2019
- Published by Evereth Publishing in Forum Zakażeń
- Vol. 10 (3) , 151-157
Przestrzeganie procedur higieny rąk przez pracowników ośrodka diagnostyki medycznej wojskowego instytutu medycznego w Warszawie